BUDESONIDE 0.5 MG/2 ML SUSP
For 1 mL
Pharmacies pay
$0.68 filed
1 × $0.67608 per ML
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$2.29 filed
1 × $2.29303 per ML, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
3.4× estimated
Medicare paid 3.4× what pharmacies pay.
Part D averages every strength and form sold under “Budesonide*” / “Budesonide” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$5.78 estimated
$0.68 + $0.10 (15%) + $5.00 fee per fill = $5.78
This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
BUDESONIDE 0.5 MG/2 ML SUSP is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “budesonide” and “budesonide inhalation”, as its NDCs’ listings variously write the nonproprietary name, under the trade name “Budesonide Inhalation Suspension”.
FDA gives its dosage form as “suspension” and “inhalant” and its route as “respiratory (inhalation)” and “oral”.
FDA lists 11 labelers (the companies named on the label) for its NDCs, among them Teva Pharmaceuticals USA, Inc., Amneal Pharmaceuticals of New York LLC and Nephron Pharmaceuticals Corporation.
FDA’s Established Pharmacologic Class for it is Corticosteroid.
The NADAC file of 2026-10-14 prices it under 15 NDCs (National Drug Codes); the FDA directory lists 14 of them.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $0.68 for 1 mL (1 × $0.67608 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size.
What NADAC measures · NADAC explanation codes
The 11 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| Cipla USA Inc. | 2 | $0.67608 per ML filed |
| Nephron Pharmaceuticals Corporation | 2 | $0.67608 per ML filed |
| Teva Pharmaceuticals USA, Inc. | 2 | $0.67608 per ML filed |
| American Health Packaging | 1 | $0.67608 per ML filed |
| Amneal Pharmaceuticals of New York LLC | 1 | $0.67608 per ML filed |
| Aurobindo Pharma Limited | 1 | $0.67608 per ML filed |
| Chartwell RX, LLC | 1 | $0.67608 per ML filed |
| Exelan Pharmaceuticals, Inc. | 1 | $0.67608 per ML filed |
| Lupin Pharmaceuticals, Inc. | 1 | $0.67608 per ML filed |
| Rising Pharma Holdings, Inc. | 1 | $0.67608 per ML filed |
| Sun Pharmaceutical Industries, Inc. | 1 | $0.67608 per ML filed |
| Not listed as a package in the FDA directory | 1 | $0.67608 per ML filed |
All 15 NDCs, with labeler and price
- 00093-6816-55 · Teva Pharmaceuticals USA, Inc. · $0.67608 per ML · eff. 2026-09-23 filed
- 00093-6816-73 · Teva Pharmaceuticals USA, Inc. · $0.67608 per ML · eff. 2026-09-23 filed
- 00115-1689-74 · Amneal Pharmaceuticals of New York LLC · $0.67608 per ML · eff. 2026-09-23 filed
- 00487-9701-01 · Nephron Pharmaceuticals Corporation · $0.67608 per ML · eff. 2026-09-23 filed
- 00487-9701-30 · Nephron Pharmaceuticals Corporation · $0.67608 per ML · eff. 2026-09-23 filed
- 47335-0632-49 · Sun Pharmaceutical Industries, Inc. · $0.67608 per ML · eff. 2026-09-23 filed
- 59651-0585-30 · Aurobindo Pharma Limited · $0.67608 per ML · eff. 2026-09-23 filed
- 60687-0524-83 · American Health Packaging · $0.67608 per ML · eff. 2026-09-23 filed
- 62135-0823-84 · Chartwell RX, LLC · $0.67608 per ML · eff. 2026-09-23 filed
- 64980-0639-03 · Rising Pharma Holdings, Inc. · $0.67608 per ML · eff. 2026-09-23 filed
- 68180-0984-30 · Lupin Pharmaceuticals, Inc. · $0.67608 per ML · eff. 2026-09-23 filed
- 69097-0319-53 · Cipla USA Inc. · $0.67608 per ML · eff. 2026-09-23 filed
- 69097-0319-87 · Cipla USA Inc. · $0.67608 per ML · eff. 2026-09-23 filed
- 76204-0018-01 · not listed as a package in the FDA directory · $0.67608 per ML · eff. 2026-09-23 filed
- 76282-0641-38 · Exelan Pharmaceuticals, Inc. · $0.67608 per ML · eff. 2026-09-23 filed
Other strengths, forms and brands
12 other products in the NADAC file share an FDA nonproprietary name with BUDESONIDE 0.5 MG/2 ML SUSP.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| BUDESONIDE 0.25 MG/2 ML SUSP | $0.6974 per ML filed | $2.29303 per ML filed |
| BUDESONIDE 0.5 MG/2 ML SUSP this page | $0.67608 per ML filed | $2.29303 per ML filed |
| BUDESONIDE 1 MG/2 ML INH SUSP | $3.42737 per ML filed | $2.29303 per ML filed |
| BUDESONIDE 2 MG RECTAL FOAM | $9.56406 per GM filed | We don’t know yet |
| BUDESONIDE 32 MCG NASAL SPRAY | $1.41168 per ML filed | We don’t know yet |
| BUDESONIDE DR 3 MG CAPSULE | $0.49753 per EA filed | $1.28354 per EA filed |
| BUDESONIDE EC 3 MG CAPSULE | $0.49753 per EA filed | $1.95114 per EA filed |
| BUDESONIDE ER 9 MG TABLET | $15.54905 per EA filed | $12.69315 per EA filed |
| EOHILIA 2 MG/10 ML PACKET | $3.28718 per ML filed | $3.03401 per ML filed |
| PULMICORT 0.5 MG/2 ML RESPULE | $4.9112 per ML filed | $5.53027 per ML filed |
| PULMICORT 1 MG/2 ML RESPULE | $9.8448 per ML filed | $5.53027 per ML filed |
| PULMICORT 90 MCG FLEXHALER | $188.51627 per EA filed | We don’t know yet |
| PULMICORT 180 MCG FLEXHALER | $253.49738 per EA filed | We don’t know yet |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. between 2026-01-21 and 2026-09-23 (4 dates) · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 15 NDCs’ NADAC prices is $0.67608 per ML filed.
Of the 106 other products in FDA’s Corticosteroid class priced per ML, 72 have a higher middle NADAC price and 34 a lower one. The one in the middle is HYDROCORTISONE BUTYR 0.1% SOLN, at $2.17643 per ML filed (eff. 2026-06-17).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-06-17, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $2.29 for 1 mL, at an average of $2.29303 per ML in 2024 (2024-01-01 to 2024-12-31) for “Budesonide*” and “Budesonide”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 173,739 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
11 of the product’s 15 NDCs have this Medicare figure; the other 4 do not, and the interactive card says why for each.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 1 mL? Is it lower than what I would pay through my insurance?
- How much is in the package I am getting? This page uses 1 mL; your package may hold a different amount.
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for BUDESONIDE 0.5 MG/2 ML SUSP labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Budesonide* / Budesonide: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's ML. Joined on generic name. *: CMS says this average reflects multiple routes of administration, which may have different unit prices. Only NADAC NDCs whose FDA route includes RESPIRATORY (INHALATION) point at this name (22 of the 32 the name join matched); NDCs of another route or with no known FDA route do not. 31 of 32 NADAC NDCs joined to this name are priced per ML (1 per GM): CMS's average mixes those units.
- Why does this page start at 1 mL?
- The FDA package descriptions of this product’s NDCs give different amounts (60 mL, 300 mL). So the card starts at 1 ML; change it to match your prescription.
Related pages
Its pharmacologic class
Related in the same class
- PREDNISONE 1 MG TABLET
- TRELEGY ELLIPTA 100-62.5-25
- METHYLPREDNISOLONE 16 MG TAB
- PREDNISOLONE AC 1% EYE DROP
- BREO ELLIPTA 100-25 MCG INHALR